Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety ...

Ivarmacitinib at both 4 mg and 8 mg doses was found to be efficacious in treating alopecia areata in a phase 3 trial.

Primary care clinicians are often the most accessible to patients and play a crucial role in the early detection and ...